Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$33.37 -0.04 (-0.12%)
As of: Nov 11, 2026 · 2:50 PM EST

Lakefront Biotherapeutics (LKFT) Cash & Equivalents (2013 - 2026)

Updated

Lakefront Biotherapeutics' Cash & Equivalents came in at $78.21 million for the quarter ended Mar 31, 2026, down 31.2% from $113.67 million a year earlier and down 23.5% from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) Cash & Equivalents (2013 - 2026) Analysis & Trends

As of Dec 31, 2025, Lakefront Biotherapeutics' Cash & Equivalents was $99.27 million, up 42.8% from the prior year.

  • Cash & Equivalents carries a five-year compound annual growth rate of -47.3% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Cash & Equivalents was $69.53 million in the year ended Dec 31, 2024 (-87.3%), $546.7 million in the year ended Dec 31, 2023 (+2.1%), $535.53 million in the year ended Dec 31, 2022 (-79.7%) and $2.64 billion in the year ended Dec 31, 2021 (+8.4%).
  • The five-year range for quarterly Cash & Equivalents is $60.98 million (the quarter ended Sep 30, 2024) to $3.18 billion (the quarter ended Jun 30, 2021).
  • Year-over-year, Cash & Equivalents increased in three of the last six quarters, with an average decline of 11.1%.
  • The fastest year-over-year change in Cash & Equivalents over five years came in the quarter ended Dec 31, 2025 (growth of 49.0%), and the weakest in the quarter ended Sep 30, 2024 (a decline of 89.0%).
  • Business Quant data shows LKFT's Cash & Equivalents at $102.28 million (quarter ended Dec 31, 2025), $75.35 million (quarter ended Sep 30, 2025) and $81.13 million (quarter ended Jun 30, 2025) in the three quarters before the quarter ended Mar 31, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 16.91 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 9.55 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 400.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 7.94 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 6.44 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.82 Bn
10 Lakefront Biotherapeutics 2.20 Bn 2.20 Bn 3.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 76.56 Mn
Dec 31, 2025 103.22 Mn
Sep 30, 2025 75.62 Mn
Jun 30, 2025 84.05 Mn
Mar 31, 2025 116.97 Mn
Dec 31, 2024 66.85 Mn
Sep 30, 2024 62.02 Mn
Mar 31, 2024 79.20 Mn
Dec 31, 2023 184.63 Mn
Sep 30, 2023 168.34 Mn
Mar 31, 2023 135.36 Mn
Dec 31, 2022 541.69 Mn
Mar 31, 2022 1.40 Bn
Dec 31, 2021 2.53 Bn
Jun 30, 2021 3.15 Bn
Dec 31, 2020 2.63 Bn
Jun 30, 2020 2.68 Bn
Mar 31, 2020 3.03 Bn
Dec 31, 2019 2.09 Bn
Sep 30, 2019 6.13 Bn
API Access

Lakefront Biotherapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=LKFT&period=max&api_key=YOUR_API_KEY